Lifevantage Corporation Common Stock (Delaware) (LFVN)

About LFVN

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; Lif…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

232

Website

www.lifevantage.com/

Fundamentals

1-day range

$5.86$6.63

Market cap

$83.01M

P/E (trailing)

14.23

P/E (forward)

30.26

EPS (trailing)

$0.45

Dividend yield

2.41%

Beta

0.75

Avg. volume

362.4K

Ex-dividend date

September 1, 2026

Dividend pay date

September 15, 2026

Forecasts

2 analyst ratings

Lifevantage Corporation Common Stock (Delaware) Competitors

Chosen by industry and closest market cap.

• LFVN

  Lifevantage Corporation Common Stock (Delaware)

  $6.6

  ▲ 2.33%
  Market cap $83.01MP/E 14.23
  $3.9$14.28
• NMAD

  Nomad Power Solutions Inc. Common Stock

  $4.33

  ▼ 2.04%
  Market cap $81.57MP/E —
  $3.12$7.7
• ATHE

  Alterity Therapeutics Limited American Depositary Shares

  $4.51

  ▼ 1.10%
  Market cap $80.78MP/E —
  $0.01$0.785
• TELO

  Telomir Pharmaceuticals Inc. Common Stock

  $1.14

  ▼ 4.20%
  Market cap $80.47MP/E —
  $0.8884$2.09
• MAIA

  MAIA Biotechnology Inc. Common Stock

  $1.33

  ▼ 3.99%
  Market cap $80.26MP/E —
  $0.87$3.19
• ACET

  Adicet Bio Inc. Common Stock

  $9.05

  ▲ 0.44%
  Market cap $86.38MP/E —
  $6.01$17.44
• NTHI

  NeOnc Technologies Holdings Inc. Common Stock

  $4.69

  ▲ 1.74%
  Market cap $89.73MP/E —
  $3.01$12.99

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6
  benzinga · 8/28/2026
• Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6
  Benzinga · 8/28/2026
• LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
  SeekingAlpha · 8/27/2026
• 12 Consumer Staples Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/27/2026
• Lifevantage Q4 2026 Earnings Call Transcript
  Benzinga · 8/27/2026
• LifeVantage Plans To Not Issue FY27 Outlook Due To Recent CEO Transition
  Benzinga · 8/27/2026
• Lifevantage Q4 Adj. EPS $0.11 Misses $0.13 Estimate, Sales $42.377M Miss $45.949M Estimate
  Benzinga · 8/27/2026
• LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  Yahoo · 8/11/2026
• LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer
  Yahoo · 8/5/2026

• Terrence Moorehead · August 6, 2026 · Grant

  540.1K
• Terrence Moorehead · August 6, 2026 · Grant

  308.6K
• Kristen Cunningham · July 1, 2026 · Tax Withholding

  1.7K @ $6.25
• Carl Aure · July 1, 2026 · Tax Withholding

  1.4K @ $6.25
• Alissa Neufeld · July 1, 2026 · Tax Withholding

  1.3K @ $6.25
• Michael A. Beindorff · June 3, 2026 · Sale

  10.0K @ $8.55
• Kristen Cunningham · April 1, 2026 · Tax Withholding

  1.9K @ $4.2
• Carl Aure · April 1, 2026 · Tax Withholding

  1.5K @ $4.2
• Alissa Neufeld · April 1, 2026 · Tax Withholding

  1.4K @ $4.2
• Steven R. Fife · April 1, 2026 · Tax Withholding

  8.2K @ $4.2
• Darwin Lewis · March 16, 2026 · Buy

  1.1K @ $5.23
• Judd Dayton · March 2, 2026 · Buy

  10.5K @ $4.53

Institutional Ownership

March 31, 2026

Total shares held

7.57M

Total value held

$32.48M

Institutional holders

99